Edwards Lifesciences EW unveiled fourth quarter financial results last night that beat expectations thanks to accelerating demand for its minimally invasive artificial heart valve So why is the medical device company s share price dropping more than 9 in recent market action A pair of analysts downgraded the stock warning that sales of